Curtin University Homepage
  • Library
  • Help
    • Admin

    espace - Curtin’s institutional repository

    JavaScript is disabled for your browser. Some features of this site may not work without it.
    View Item 
    • espace Home
    • espace
    • Curtin Research Publications
    • View Item
    • espace Home
    • espace
    • Curtin Research Publications
    • View Item

    Characteristics, retention and readmissions of opioid-dependent clients treated with oral naltrexone

    Access Status
    Fulltext not available
    Authors
    Bartu, Anne
    Freeman, N.
    Gawthorne, G.
    Allsop, Steve
    Quigley, A.
    Date
    2002
    Type
    Journal Article
    
    Metadata
    Show full item record
    Citation
    Bartu, Anne and Freeman, Nerelie and Gawthorne, Geoff and Allsop, Steven and Quigley, Allan . 2002. Characteristics, retention and readmissions of opioid-dependent clients treated with oral naltrexone. Drug and Alcohol Review. 21 (4): pp. 335-340.
    Source Title
    Drug and Alcohol Review
    DOI
    10.1080/0959523021000023180
    ISSN
    09595236
    Faculty
    Faculty of Health Sciences
    National Drug Research Institute (Research Institute)
    School
    School of Nursing and Midwifery
    URI
    http://hdl.handle.net/20.500.11937/20544
    Collection
    • Curtin Research Publications
    Abstract

    The aims of this study were to examine the retention rates of opiod-dependent clients treate with oral naltrexone and identify factors that influence retention in treatement of 981 opioid-dependent clients at a public out-patient clinic in Perth, Western Australia. The average retention period for all clients was 9.0 weeks. The factors associated with longer retention were being employed and referral source. Clients who were employed stayed significantly longer in treatment than unemployed clients. Clients referred from a pricate clinic were retained in treatment significantly longer than those referred from other sources (X=10.3 vs. 5.9 weeks). While the majority (80.8%) had one admission to naltrexone treatment, 19.2% presented for readmission, some on three or more ocassions in the study period. The median period between the end of the first episode of treatment and commencement of the second was 15.6 weeks. The median period between the end of the second episode of treatment and commencement of the third was 11.4 weeks. Those employed had a higher probability of being retained longer in treatment than those who were unemployed in subsequent treatment episodes. Clinicians should respect that initial retention in naltrexone is likely to be relatively short, and that a substantial proportion of clients will represent for further treatment.

    Related items

    Showing items related by title, author, creator and subject.

    • Risk factors for craving and relapse in heroin users treated with oral or implant naltrexone
      Hulse, G.; Ngo, H.; Tait, Robert (2010)
      Background: Oral naltrexone effectively antagonizes heroin, but patient noncompliance limits its utility; sustained-release preparations may overcome this. Few data are available on optimal blood naltrexone levels for ...
    • Blood naltrexone levels over time following naltrexone implant
      Ngo, H.; Arnold-Reed, D.; Hansson, R.; Tait, Robert; Hulse, G. (2008)
      Aims: Oral naltrexone is used in the management of both heroin and alcohol dependence. However, poor compliance has limited its clinical utility. The study's objective was to determine the period of therapeutic coverage ...
    • Improving clinical outcomes in treating heroin dependence: randomized, controlled trial of oral or implant naltrexone
      Hulse, G.; Morris, N.; Arnold-Reed, D.; Tait, Robert (2009)
      CONTEXT: Oral naltrexone hydrochloride effectively antagonizes heroin, but its utility is limited by patient noncompliance. Sustained-release preparations may overcome this limitation.OBJECTIVE: To compare the safety and ...
    Advanced search

    Browse

    Communities & CollectionsIssue DateAuthorTitleSubjectDocument TypeThis CollectionIssue DateAuthorTitleSubjectDocument Type

    My Account

    Admin

    Statistics

    Most Popular ItemsStatistics by CountryMost Popular Authors

    Follow Curtin

    • 
    • 
    • 
    • 
    • 

    CRICOS Provider Code: 00301JABN: 99 143 842 569TEQSA: PRV12158

    Copyright | Disclaimer | Privacy statement | Accessibility

    Curtin would like to pay respect to the Aboriginal and Torres Strait Islander members of our community by acknowledging the traditional owners of the land on which the Perth campus is located, the Whadjuk people of the Nyungar Nation; and on our Kalgoorlie campus, the Wongutha people of the North-Eastern Goldfields.